ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
30
views
0
references
Top references
cited by
42
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
976
similar
All similar
Record
: found
Abstract
: found
Book
: found
Is Open Access
The EBMT Handbook
other
Editor(s):
Enric Carreras
,
Carlo Dufour
,
Mohamad Mohty
,
Nicolaus Kröger
Publication date
(Print):
2019
Publisher:
Springer International Publishing
Read this book at
Publisher
Buy book
Download
Download
PDF
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
The Handbook of Systems Thinking
Author and book information
Book
ISBN (Print):
978-3-030-02277-8
ISBN (Electronic):
978-3-030-02278-5
Publication date (Print):
2019
DOI:
10.1007/978-3-030-02278-5
SO-VID:
2f1c94ea-e37b-45d3-98ac-9b7eea1b190e
License:
https://creativecommons.org/licenses/by/4.0
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. 3
HSCT: Historical Perspective
pp. 11
The EBMT: History, Present, and Future
pp. 19
The Role of Unrelated Donor Registries in HSCT
pp. 27
The HSCT Unit
pp. 35
JACIE Accreditation of HSCT Programs
pp. 41
Statistical Methods in HSCT and Cellular Therapies
pp. 49
Biological Properties of HSC: Scientific Basis for HSCT
pp. 57
Biological Properties of Cells Other Than HSCs
pp. 61
Histocompatibility
pp. 69
Clinical and Biological Concepts for Mastering Immune Reconstitution After HSCT: Toward Practical Guidelines and Greater Harmonization
pp. 77
Evaluation and Counseling of Candidates
pp. 87
Donor Selection for Adults and Pediatrics
pp. 99
Conditioning
pp. 109
Bone Marrow Harvesting for HSCT
pp. 123
Collection of HSC in Children
pp. 131
Procurement and Management of Cord Blood
pp. 137
Graft Manipulation
pp. 143
Documentation of Engraftment and Chimerism After HSCT
pp. 149
Short- and Long-Term Controls After HSCT
pp. 157
Vascular Access
pp. 163
Transfusion Support
pp. 171
Nutritional Support
pp. 177
GVHD Prophylaxis (Immunosuppression)
pp. 183
Management ATG (SIRS)
pp. 207
Vaccinations
pp. 221
Psychological Morbidity and Support
pp. 229
Clinically Relevant Drug Interactions in HSCT
pp. 237
Role of Nursing in HSCT
pp. 245
Ethical Issues in HSCT
pp. 251
Quality of Life Assessment After HSCT for Pediatric and Adults
pp. 259
Neutropenic Fever
pp. 265
Bacterial Infections
pp. 273
Invasive Fungal Infections
pp. 281
Viral Infections
pp. 291
Other Life-Threatening Infections
pp. 301
Bleeding and Thrombotic Complications
pp. 307
Graft Failure
pp. 315
Early Complications of Endothelial Origin
pp. 323
Acute Graft-Versus-Host Disease
pp. 331
Chronic Graft-Versus-Host Disease
pp. 347
Post transplant Lymphoproliferative Syndromes
pp. 353
Iron Overload
pp. 357
Secondary Neoplasia (Other than PTLPS)
pp. 367
Ocular and Oral Complications
pp. 373
Hepatic Complications
pp. 381
Gastrointestinal Complications
pp. 387
Haemorrhagic Cystitis and Renal Dysfunction
pp. 393
Noninfectious Pulmonary Complications
pp. 403
Neurological Complications
pp. 409
Skin, Hair and Musculoskeletal Complications
pp. 415
Cardiovascular Diseases and Metabolic Syndrome
pp. 421
Endocrine Disorders, Fertility and Sexual Health
pp. 431
Monitoring Minimal Residual Disease in ALL and AML
pp. 437
Prevention and Treatment of Relapse by Drugs
pp. 443
Delayed Transfer of Immune Cells or the Art of Donor Lymphocyte Infusion
pp. 449
Cellular Therapy with Engineered T Cells, Efficacy and Side Effects
pp. 457
Mechanisms of Immune Resistance
pp. 461
Regulatory Aspects of ATMP Versus Minimally Manipulated Immune Cells
pp. 467
At-Home HSCT
pp. 473
Umbilical Cord Blood Transplantation in Children and Adults
pp. 479
Haploidentical HSCT
pp. 487
Photopheresis in Adults and Pediatrics
pp. 493
Overweight and Obese Patients
pp. 499
HSCT in Elderly Patients
pp. 507
Acute Myeloid Leukemia in Adults
pp. 523
Acute Myeloid Leukemia in Children
pp. 531
Acute Lymphoblastic Leukemia in Adults
pp. 539
Acute Lymphoblastic Leukemia in Children and Adolescents
pp. 547
Myelodysplastic Syndromes
pp. 557
Pediatric MDS Including Refractory Cytopenia and Juvenile Myelomonocytic Leukemia
pp. 561
Myelodysplastic/Myeloproliferative Neoplasms
pp. 569
Myeloproliferative Neoplasms
pp. 579
Severe Aplastic Anemia and PNH
pp. 587
Fanconi’s Anemia and Other Hereditary Bone Marrow Failure Syndromes
pp. 595
Hemoglobinopathies (Sickle Cell Disease and Thalassemia)
pp. 603
Multiple Myeloma
pp. 609
Systemic Light Chain Amyloidosis
pp. 615
POEMS Syndrome and Disease Produced by Other Monoclonal Immunoglobulins
pp. 621
Follicular Lymphoma
pp. 627
Chronic Lymphocytic Leukemia
pp. 633
Diffuse Large B-Cell Lymphoma
pp. 643
Mantle Cell Lymphoma
pp. 647
Other T- and B-Aggressive Lymphomas and Lymphomas Associated with HIV
pp. 653
Classical Hodgkin’s Lymphoma
pp. 663
Primary Immunodeficiencies
pp. 671
Inborn Errors of Metabolism and Osteopetrosis
pp. 677
Autoimmune Disease
pp. 685
Solid Tumours
Similar content
976
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Following Total Body Irradiation- the Effect of Anti- Thymocyte Globulin on Transplant Outcome: ALWP of the EBMT Study
Authors:
Arnon Nagler
,
Myriam Labopin
,
Riitta Niittyvuopio
…
Calcineurin Inhibitor Alone or in Combination with Mycophenolate Mofetil for Graft-Versus-Host-Disease Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Transplantation from Matched Unrelated Donors: A Study from the ALWP of the EBMT
Authors:
Annalisa Paviglianiti
,
Myriam Labopin
,
Didier Blaise
…
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
Authors:
W Wiktor-Jedrzejczak
,
J. Drozd-Sokolowska
,
D. Eikema
…
See all similar
Cited by
36
Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Authors:
Mauro Krampera
,
Katarina Le Blanc
The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
Authors:
Riccardo Masetti
,
Daniele Zama
,
Davide Leardini
…
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party
Authors:
Donal P McLornan
,
Juan Boluda
,
Tomasz Czerw
…
See all cited by